Barinthus Biotherapeutics plc.
Develops T cell immunotherapies for autoimmune and chronic infectious diseases.
BRNS | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 20400 CENTURY BLVD, 20874 GERMANTOWN
- Website:
- https://www.barinthusbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Barinthus Biotherapeutics plc (formerly Vaccitech plc) is a clinical-stage biopharmaceutical company developing a new generation of immunotherapies. The company's core approach involves creating treatments designed to guide T cells to control and overcome disease. Its therapeutic pipeline is primarily focused on immunology and inflammatory (I&I) indications, including autoimmune diseases and chronic infectious diseases, by aiming to promote specific immune responses and tolerance.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Barinthus Biotherapeutics plc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Barinthus Biotherapeutics plc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Barinthus Biotherapeutics plc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
